Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
Zagazig University
Memorial Sloan Kettering Cancer Center
University of Nebraska
AC Camargo Cancer Center
University Health Network, Toronto
IRCCS San Raffaele
Arab American University (Palestine)
Washington University School of Medicine
Compugen Ltd
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Universidade Federal de Pernambuco
Taproot Health
Sanguine Biosciences
Case Comprehensive Cancer Center
Weprom
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
CureOne
Amgen
Leaf Vertical Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
SPGO Research Mannheim GmbH
M.D. Anderson Cancer Center
Stanford University
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca